Activation of the Met tyrosine kinase growth factor receptor by its ligand HGF/SF has been shown to increase in vitro invasiveness in epithelial cell lines. To study the eect of Met-HGF/SF signaling in breast cancer cells, we transfected met, hgf/sf and dominant negative (DN) forms of met into the poorly dierentiated metastatic murine mammary adenocarcinoma cell line DA3. These cells express moderate levels of endogenous Met, which is rapidly phosphorylated in response to HGF/SF treatment. Met+hgf/sf transfection results in signi®cantly increased tumorigenic and metastatic activity in vivo accompanied by reduced tubule formation. DA3 cells transfected with DN forms of Met (DN-DA3) exhibit reduced Met phosphorylation following exposure to HGF/SF. Furthermore, as compared to the parental cells, the DN-DA3 cells exhibit diminished in vitro scattering and invasiveness, while in vivo they display greatly reduced tumorigenicity and spontaneous metastasis. Tumors emanating from DN-DA3 cells injected to BALB/C mice are highly dierentiated and display extensive tubule formation. These results suggest that Met-HGF/SF signaling is a determining factor in the delicate balance between dierentiation/tubule formation and tumorigenicity-metastasis.
Introduction
Breast cancer is a multi-step process, which proceeds from pre-neoplastic disease through invasive cancer, lymphatic spread and metastasis (Benz et al., 1995) . A number of growth factors and their receptors have been implicated in breast tumor formation and progression. Their involvement in mammary carcinogenesis has been associated with alteration in their number, structure, or sub-cellular location (Cunha, 1994) .
Recently, attention has focused on the role of Met tyrosine kinase growth factor receptor and its ligand hepatocyte growth factor/scatter factor (HGF/SF) in mammary development and carcinogenesis Tsarfaty et al., 1992; Yamashita et al., 1994; Yang et al., 1995) . HGF/SF is a paracrine factor, produced primarily by mesenchymal cells, which induces mitogenic, motogenic and morphogenic changes. The diverse biological eects of HGF/SF are all mediated by Met, which is preferentially expressed on epithelial cells (Jeers et al., 1996a) . In vivo, this receptor-ligand pair is essential for normal embryological development Schmidt et al., 1995) . Null mutations in both HGF/SF (Schmidt et al., 1995) and Met (Uehara et al., 1995) are embryonic lethal.
We have shown that Met-HGF/SF signaling plays an important role in epithelial tissue morphogenesis and lumen formation (Tsarfaty et al., 1992 (Tsarfaty et al., , 1994 . HGF/SF has been shown to induce tubular branching of mammary cell lines in collagen gels (Berdichevsky et al., 1994; Soriano et al., 1995) and to be involved in the development of mammary tubular structures in vivo . While Met-HGF/SF signaling clearly plays a role in normal cellular processes, this signaling pathway has also been implicated in tumor development and progression. Met-HGF/SF signaling can increase tumorigenicity (Rong et al., 1992) , induce cell motility (Stoker et al., 1987) , enhance in vitro invasiveness (Giordano et al., 1993; Jeers et al., 1996a; Matsumoto et al., 1994; Rong et al., 1994) and in vivo metastasis (Jeers et al., 1996b; Rong et al., 1994; Rosen et al., 1994) . In addition, Met-HGF/SF signaling can increase production of proteases and urokinase (Jeers et al., 1996b) which are associated with extracellular matrix/basal membrane degradation important for metastasis. HGF/SF is a potent angiogenic factor (Bussolino et al., 1992; Rosen et al., 1993) that induces blood vessel formation in tumors originating from injection of human breast cancer cells into the mammary fat pads of nude mice . Furthermore, HGF/SF transgenic mice develop a broad array of histologically distinct tumors of both mesenchymal and epithelial origin (Takayama et al., 1997) . Activating mutations in the tyrosine kinase domain of Met have been identi®ed in both hereditary and sporadic forms of human papillary renal carcinoma .
Constitutive activation of growth factor receptors through autocrine ligand stimulation frequently occurs in human cancers (Ethier, 1995) . We previously demonstrated that when Met and its ligand are co-expressed in a variety of mouse and human cells, the cells become highly tumorigenic in nude mice through an autocrine mechanism (Cortner et al., 1995; Rong et al., 1992 Rong et al., , 1995 . Additional reports describe Met-HGF/SF auto-crine loops in murine mammary carcinoma cells inducing in vitro invasiveness (Jeers et al., 1996a; Rahimi et al., 1996) . NIH3T3 cells co-transfected with met and hgf/sf form tumors in nude mice. These mesenchyme-derived tumor cells and explants acquire lumen-like morphology in vitro and in vivo. Furthermore, histopathological examination of paran-embedded sections of tumor derived from these cells shows that in addition to lumenal structures, they contain carcinoma-like focal areas (Tsarfaty et al., 1994) .
Met-HGF/SF signaling has been implicated in a wide range of cancers including breast cancer Tsarfaty et al., 1992; Yamashita et al., 1994; Yang et al., 1995) , but its exact role is not clearly understood. Loss of heterozygosity (LOH) for the c-met locus in breast cancer patients was described (Bieche et al., 1992; Deng et al., 1994) and has been shown to correlate with a higher risk of relapse, metastatic disease and reduced overall survival (Bieche et al., 1992) . We have shown that Met is expressed and activated in normal breast ducts and reduced in some breast tumors (Tsarfaty et al., 1992) . On the other hand, Met expression levels were shown to be signi®cantly greater for patients with breast cancer than in benign breast disease (Nagy et al., 1995) . Transgenic expression of tpr-met led to development of mammary hyperplasia and tumors (Liang et al., 1996) . Other studies show elevated HGF/SF level is a strong and independent predictor of recurrence and reduced survival in human breast cancer (Yamashita et al., 1993 (Yamashita et al., , 1994 . Invasive breast cancers have signi®cantly higher HGF/SF levels as compared with ductal carcinoma in situ, and invasive cancers that had spread to axillary lymph nodes exhibited signi®cantly higher HGF/SF content than did invasive cancers without regional spread (Yao et al., 1996) . We have recently shown that either increased or decreased Met expression in breast tumors indicates poor prognosis (Tsarfaty et al., 1999) .
Receptor dimerization has been proposed to be necessary for receptor tyrosine kinase activation (Yarden and Schlessinger, 1987) . Receptor dimerization is followed by intramolecular transphosphorylation of the receptor sub-units, which initiates intracellular signal transduction. In vivo, expression of certain mutated receptors, referred to as dominant-negative receptors, can disrupt receptor signaling by hetero-dimerization with the wild type receptors (Amaya et al., 1991) or by sequestering ligand (Robinson et al., 1995) . In either case, the consequence is a signi®cant reduction in ligand-receptor association-induced activity.
To further elucidate the contribution of Met-HGF/ SF signaling to breast cancer, we examined the eect of both up-and down-regulation of Met expression and activity on the tumorigenic and invasive potential of a mammary cell line, using the DA3 cell line as a model system. Up-regulation of Met activity was accomplished by co-transfection with expression vectors for Met and HGF/SF. The down-regulation of Met activity was achieved by constructing two dominantnegative forms of Met (DN-Met): One was truncated at the kinase domain; the other produced by the substitution of three tyrosines in the docking site (F1DN). We found that a reduction in Met signaling in DA3 cells (via DN-Met) induced in vitro and in vivo tubulogenesis, whereas an elevation in Met signaling induced enhanced motility, tumorigenicity and metastasis. Our results demonstrate that Met-HGF/SF signaling can alternate the fate of the cells between cell dierentiation (tubulogenesis) and invasive-metastatic phenotype.
Results

Expression of HGF/SF, Met and DN-Met in DA3 cells
Met expression in DA3 cells was determined by Western blot (WB) analysis with SP260 rabbit antipeptide antibody. Moderate levels of p140 met were detected ( Figure 1A , lane 1). This band was not evident in the presence of SP260 immunizing peptide ( Figure 1A , lane 2), con®rming the speci®city of the antibody. The in¯uence of HGF/SF on Met phosphorylation was determined by immunoprecipitation (IP) using SP260 followed by WB analysis using antiphosphotyrosine antibody (anti-pTyr). Low levels of phosphorylated Met were detected in the untreated DA3 cells ( Figure 1A , lane 3). A 5-minute exposure to HGF/SF increased (410 fold) Met phosphorylation ( Figure 1A , lane 4). Thus, Met is present and is rapidly phosphorylated in response to HGF/SF treatment.
In order to investigate the eects of Met-HGF/SF signal transduction modulation on mammary cells, DA3 cells were transfected with human hgf/sf (DA3H), murine met (DA3M), or both human hgf/sf and murine met (DA3MH). DA3 cells transfected with expression vector containing only neo (DA3N) served as control. In addition to the clones isolated, we pooled at least 50 resistant colonies (clones) of DA3 cells transfected with hgf/sf (PL-DA3H) or with met+hgf/sf (PL-DA3MH) in order to avoid misleading conclusions resulting from clonal variation. We evaluated HGF/SF expression levels in the supernatants of the transfected cells by heparin-sepharose precipitation and WB analysis. Expression of HGF/SF was not detected in DA3N supernatant ( Figure 1Bb , lane 1), while PL-DA3H and PL-DA3MH supernatants exhibited high levels of HGF/SF (Figure 1Bb , lanes 2 and 3, respectively) with HMH cell supernatant used as positive control ( Figure  1Bb , lane 4). Immuno¯uorescence (IF) analysis also showed no expression of HGF/SF in DA3N cells (Figure 1Ba, 1) , while DA3H cells exhibited high levels of HGF/SF (Figure 1Ba , 2). DA3MH cells displayed the highest HGF/SF expression levels of all the transfected clones (Figure 1Ba, 3) .
We transfected DA3 cells with forms of Met that were partially deleted at the tyrosine kinase (TK) domain (pMBTDN-TDN cells) or contained substitution of three tyrosine residues (Y1347, Y1354 and Y1363) with phenylalanine in the docking site (pMFDN-F1DN cells) as potential dominant negative forms of Met. Mutation of these docking site tyrosines was previously demonstrated to abrogate Met activity (Ponzetto et al., 1994; . In addition to the selected individual clones transfected with pMFDN, we pooled at least 50 neo-resistant clones (PL-FDN) in order to avoid misleading conclusion resulting from clonal variation. We also constructed an additional TDN-Met expression plasmid with a in¯uenza hemagglutinin (HA) tag (pTDN-HA). DA3 cells were transfected with pTDN-HA and at least 50 neo-resistant clones were pooled (PL-TDN-HA). We also tested several TDN-HA clones.
We proceeded to verify the transfections. TDN-Met (pMBTDN) transcription in TDN cells was determined by RT ± PCR. The transcribed pMBTDN DNA is 651 bp shorter than the wild-type cDNA. RT ± PCR of DA3N yielded the expected fragment of 1004 bp ( Figure 1C , lane 1) comparable to the PCR product obtained with wild-type met cDNA plasmid (pMB11) ( Figure 1C, lane 3) . RT ± PCR of TDN cells produced three fragments ( Figure 1C , lane 2): one of 1004 bp, corresponding to the endogenous Met, another of 352 bp, indicating the deletion, comparable to the PCR product obtained with DN met plasmid (pMBTDN) ( Figure 1C , lane 4), and a third of *700 bp, which is currently under investigation.
To verify truncated Met expression, 293 human embryonic kidney cells, which do not express endogenous Met detectable with the SP260 antibody, were transiently transfected with pMBTDN (293-TDN) or pMB11 (293-Met). These cells were subjected to IP and WB analysis using SP260 anti Met Ab. A band of approximately 120 kDa appears only in the 293-TDN cells ( Figure 1D , lane 3) but not in 293 cells ( Figure  1D , lane 1) or in 293-Met cells ( Figure 1D , lane 2). IP and WB analysis using SP260 anti Met Ab shows that a corresponding 120 kD band appears in TDN cells ( Figure 1D , lane 6) but not in DA3 cells ( Figure 1D , lane 5). Hence, the truncated Met is expressed at both the mRNA and protein levels. Truncated Met expression in the TDN-HA clones was examined by IP of the cell lysate with SP260 anti Met Ab and subsequent WB with monoclonal anti HA Ab. A band of approximately 120 kD appears only in the TDN-HA clones ( Figure 2C , lanes 3 ± 10) but not in DA3N cells ( Figure  2C , lanes 1 and 2) verifying the expression of truncated (2) and DA3MH (3) cells were stained with rabbit anti recombinant human HGF/SF antibody, labeled with donkey anti rabbit antibody conjugated to FITC and analysed using CLSM. HGF/SF is not detected in DA3N cells while DA3H cells express moderate levels of HGF/SF, and DA3MH cells express greater levels (magni®cation 6260). (b) WB of HGF/SF expression in DA3 transfectants. Supernatants from DA3N (1), PL-DA3H (2), PL-DA3MH (3) and HMH (4) cells were incubated with heparin-sepharose (HS). Following incubation pellets were suspended in sample buer, resolved on 12% SDS ± PAGE and analysed by Western blot analysis using rabbit anti HGF/SF antibody diluted 1 : 350. HGF/SF is secreted from PL-DA3H and PL-DA3MH cells. (C) Analysis of truncated dominant negative met mRNA transcription. Ethidium bromide stained agarose gel of 3' met RT ± PCR on RNA extracts from DA3N cells (1) and TDN cells (2); PCR product from 3' met primers on full-length met cDNA plasmid pMB11 (3) and pMBTDN plasmid (4) Figure 2E ). Expression of tyrosine-mutated Met (FDN) was more dicult to verify since the mutated Met is indistinguishable from wild-type Met by WB. However, the construct was transiently transfected into 293 cells and its expression was examined by IP and WB with SP260. The transfected 293-FDN cells exhibited high mutated Met levels ( Figure 1D , lane 4) as opposed to the parental 293 cells ( Figure 1D , lane 1). Hence, the FDN protein is expressed in cells.
HGF/SF-induced Met phosphorylation in transfectants
We proceeded to determine the eect of the various transfections on Met phosphorylation in DA3 cells exposed to HGF/SF. DA3N, DA3MH and the DA3 cells transfected with the DN forms of met, were treated with HGF/SF for various times. Subsequently, the cell extracts were examined for Met expression ( Figure 2D , lanes 3 ± 10) compared to DA3N cells ( Figure 2D, lanes 1 and 2) .
Proliferation of DA3 and transfectants following Met activation
We examined cell proliferation of DA3 and the various transfectants. Cells (2500/well) were incubated with or without HGF/SF (80 u/ml) for 96 h. Proliferation was determined using MTT assay ( Figure 3A ).
Exposure to HGF/SF had no eect on the proliferation rate of the various transfectants, with the exception of DA3M, which displayed a 31% 
Scattering and in vitro invasiveness of DA3 and transfectants
Motility and invasiveness are characteristics of malignant cells. DA3 treated with HGF/SF (80 u/ml) display ®broblast-like`scattered' morphology ( Figure  3B , 2) as compared to appearance of untreated cells ( Figure 3B, 1 ). This change in morphology is similar to that of HGF/SF-treated MDCK cells (the classical model for HGF/SF-induced cell motility) exhibiting disruption and scattering of epithelial colonies. HGF/ SF also induced scattering of DA3M, DA3H and DA3MH cells (data not shown) similar to that of the parental DA3 cells. However, negligible scattering was observed in HGF/SF-treated PL-TDN-HA and PL-FDN cells ( Figure 3B , 4, 6 respectively) compared to untreated cells ( Figure 3B, 3, 5 respectively) . Similarly, no signi®cant scattering reaction was observed in HGF/SF-treated TDN and F1DN cells (data not shown).
Invasiveness of DA3 and transfectants was evaluated by Boyden chamber basement membrane matrigel assay (Albini et al., 1987) (Figure 3C ). HGF/SFtreated DA3 cells migrated through the matrigel-coated ®lter ( Figure 3C , 1, columns 1 ± 3), while no spontaneous migration was detected in the absence of HGF/ SF. HGF/SF-treated DA3MH cells eectively migrated through the matrigel-coated ®lter (data not shown). HGF/SF-induced invasiveness of TDN and F1DN cells was signi®cantly reduced in comparison with parental DA3 ( Figure 3C , 1, columns 4 ± 6 and 7 ± 9, respectively).
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Quanti®cation of migration revealed that TDN cells exhibit a 56% (P50.0001) and F1DN cells a 88% (P50.000004) reduction of in vitro invasiveness compared to the parental cell line, as determined by positive area (see Materials and methods) ( Figure 3C , 2). These results further substantiate that the DN Figure 3 (A) Proliferation rate of DA3 and transfectants. DA3N and transfectants were seeded into 96-well microtiter plates and incubated with (vertical line bars) or without HGF/SF (80 u/ml) (gray bars) for 96 h. Graph shows OD results of MTT analysis. Proliferation rate of TDN and F1DN cells is signi®cantly increased compared to DA3N cells. (B) Scattering of DA3 and transfectants. DA3 (1, 2), PL-TDN-HA (3, 4) and PL-FDN (5, 6) cells were seeded in 96-well microtiter plates and incubated for 24 h without (1, 3, 5) or with 80 u/ml of HGF/SF (2, 4, 6). Cells were ®xed, stained with Giemsa and examined by inverted microscope (magni®cation6230). (C) In vitro invasiveness of DA3 and transfectants. 1. DA3N (1 ± 3); TDN (4 ± 6) and F1DN (7 ± 9) cells were submitted in triplicate to Boyden chamber assay using basement membrane matrigel coated ®lter. HGF/SF (80 u/ml) was added (+) or not added (7) to the lower wells. Following 24 h incubation, the membrane was removed and its upper surface 
In vitro tubule formation by DA3 and transfectants
Tubule formation is a major characteristic of dierentiated mammary cells. Tubule formation in collagen was assessed for the dierent transfectants following HGF/SF treatment. Untreated DA3N, TDN and F1DN cells grow as cysts in the collagen cultures ( Figure 3D, 1, 3 and 5, respectively) . In the presence of HGF/SF, branching morphogenesis occurs in TDN and F1DN cells, which leads to outgrowth of long extensions ( Figure 3D , 4 and 6, respectively) similar to treated MDCK cells ( Figure  3D, 8) . Using CLSM we observed that the branches contained lumens (data not shown). However, HGF/ SF treatment did not induce tubule formation in DA3N cells ( Figure 3D , 2) and DA3MH (data not shown). These results indicate that reduction of Met activity enables DA3 cells to form branching tubular structures. 
Tumor formation by DA3 and transfectants
In vivo tumorigenicity of DA3 cells and transfectants was determined by intra-muscular injection of the various transfected cells into BALB/C mice. DA3 and transfectants were each injected (5610 4 cells) to 10 mice, which were subsequently monitored twice weekly for tumor formation. One month follow-up revealed: palpable tumors developed in 80% (eight of 10) of mice injected with DA3N and of DA3M-injected mice, 100% (10 out of 10) of DA3H-injected mice and of DA3MH-injected mice, but in only 40% (four of 10) of TDN-injected mice and 20% (two of 10) of F1DN-injected mice. We analysed the rate of tumor formation and overall survival for statistical signi®cance using Kaplan ± Meier plots ( Figure 4A ). This analysis shows that DA3H and DA3M cells exhibit a statistically signi®cant increase in tumor formation as compared with DA3N cells; the highest rate of tumor formation was observed in mice injected with DA3MH cells. A signi®cant reduction in tumor formation was found in mice injected with TDN cells, and the lowest tumorigenicity was observed in F1DN-injected mice. Log rank analysis shows a statistically signi®cant dierence between the dierent groups (P=0.0001).
Fifty-six days after injection, eight mice of each group were sacri®ced, tumors were excised and histopathological examination was carried out on H&E-stained tumor sections. Tumors in mice injected with DA3N cells were pleomorphic and irregular in size and shape. These tumors exhibited numerous mitotic ®gures, few micro-lumena and evidence of increased vascularity ( Figure 4B, 1) . DA3MH tumor cells were the least dierentiated, arranged in sheets and fragments with less columnar dierentiation ( Figure 4B, 2) . However, the tumors in mice injected with TDN cells were highly dierentiated and formed numerous lumenal as well as glandular structures ( Figure 4B, 3) . F1DN-injected mice developed tumors that were even more dierentiated, containing mature columnar structures with increased stroma between the glandular elements and larger columnar cells ( Figure  4B, 4) .
The lungs of the sacri®ced mice were evaluated for spontaneous metastasis formation by weight and morphological/histopathological inspection. The weight of lungs from DA3MH-injected mice was 48% (0.32+0.13 g) and DA3M-injected mice was 19% (0.25+0.04 g) greater than those of DA3N-injected mice (0.21+0.03 g). Lung weight of mice injected with TDN and F1DN cells was 13% (0.19+0.04 g) and 8% (0.20+0.04 g) less than DA3N-injected mice, respectively. Lung weight of DA3H-injected mice was similar to that of DA3N-injected mice (0.21+0.05 g). These results were substantiated by the examination of H&E stained histological sections of the lungs from ®ve mice of each group. Examination of DA3N-injected mice lung sections revealed few foci of moderately dierentiated tubular carcinoma ( Figure 4C, 1) with metastases occupying an average of 1 ± 2% of the lung area. In DA3M-injected mice sections the normal lung structure was largely destroyed by the metastatic tissue ( Figure 4C , 2) with metastases occupying an average of 5 ± 7% of the lung area. Many foci, some very large, were observed in DA3H lung sections; the tubular structure was minimal ( Figure 4C, 3) with metastases occupying an average of 8 ± 9% of the lung area. DA3MH lung sections also contained very large foci. The metastatic cells surrounded the alveolar space in solid clumps, with no tubular structure ( Figure 4C, 4) with metastases occupying an average of 25 ± 27% of the lung area. In contrast, TDN-injected mice lung sections contained few small foci. The metastatic tissue was mainly comprised of stroma, with indication of capsule formation ( Figure 4C , 5) with metastases occupying an average of 0.1% of the lung area. In F1DN lung sections, a single carcinoma-like focus was observed. The focus, which displayed little tubular dierentiation, was located in the lung periphery ( Figure 4C, 6 ) with metastases occupying an average of 0.1% of the lung area.
Additional six groups of 10 mice were injected as previously described. The mice were monitored over a period of 85 days. DA3M and DA3MH-injected mice had the shortest life spans, while the survival rates for TDN and F1DN-injected mice were remarkably longer. Results were analysed using Kaplan ± Meier statistical analysis and were determined signi®cantly dierent (P=0.0001 Log-rank) ( Figure 4D ).
Discussion
Loss of normal tubular and glandular structures is one of the primary characteristics of breast tumors. Rather than forming organized tubular structures, tumor cells proliferate and ®ll ducts and ductules. A poor degree of dierentiation or tubular organization correlates with a poor prognosis in invasive ductal carcinoma (Clark, 1996) . Understanding the molecular mechanisms underlying tubule formation and its abrogation during carcinogenesis/tumor progression may shed light on the cellular processes leading to breast cancer. Others and we have shown that activation of Met signal transduction induces lumen/tubule formation. However, up-regulation of the same signal transduction also induces invasiveness and metastasis. In order to examine the role of Met in the balance between tumorigenesis/metastasis and dierentiation/tubulogenesis, we created a model to investigate the eects of Met signaling modulation on mammary cells, both in vivo and in vitro. Our model system is based on the carcinogen-induced mouse mammary cell line DA3. These cells are highly tumorigenic and metastatic, poorly dierentiated and express moderate levels of endogenous Met. Up-regulation of Met signal transduction was achieved by co-transfection of met and hgsf/sf into DA3 cells; down-regulation of the signaling was achieved by transfection with DN forms of the Met receptor.
The DN receptor is a powerful tool in the study of receptor action and signal transduction (Ullrich and Schlessinger, 1990) . It has been demonstrated that TK truncated receptors such as the insulin receptor, EGF receptor (Qian et al., 1994) and FGF receptor (Amaya et al., 1991) can act as DN and suppress the function of WT receptors. We constructed two DN forms of Met: One consists of a deletion in the TK domain; the other has three mutated tyrosine residues (Y1347, Y1354 and Y1363) in the docking site. Both forms of DN-Met were found to reduce the in vitro motility and invasiveness, as well as in vivo tumorigenic and metastatic potential of the transfected DA3 cells.
The molecular mechanism of the DN eect caused by the truncated TK-Met receptor is not entirely clear. Since the level of TDN Met receptor expression is not high, it is less conceivable that the DN eect is due to competition for the ligand. It is more conceivable that dimerization of the truncated receptor with the WT receptor is required for DN action. These results indicate that receptor dimerization is essential for WT Met activity. This is substantiated by previous work, which demonstrates that a leucine zipper-mediated dimerization of the tpr-met product is essential for the transforming activity of the met oncogene (Rodrigues and Park, 1993) .
To our knowledge, these results are the ®rst to demonstrate that a receptor that harbors mutations in the docking site can serve as a DN molecule. Phosphorylation of tyrosines in the docking site is a crucial step in tyrosine receptor signal transduction. Mutations in these tyrosines abrogate substrate association with the receptor, blocking downstream events and rendering the receptor inactive. It has been shown that mutations in Met Y1349 and Y1356 can reduce or abrogate the binding of Met substrates PLCg, GRB-2 and pp60 c-src to Met and reduce Tpr-Met transforming ability (Ponzetto et al., 1994) . Moreover, mutation of Met tyrosine residues Y1311, Y1347, Y1354 and Y1363 reduced or abolished ligand-induced cell motility and branching morphogenesis . However, it is not entirely clear how the docking site tyrosine-mutated receptor serves as a DN, since the TK region is intact and thus theoretically it is still capable of cross-phosphorylating the endogenous WT receptor. As suggested for the TK-mutated DN, the docking site-mutated DN activity can be explained by competition with the WT receptor for the ligand or by dimerization with the WT receptor, which might sterically interfere with substrate binding to the WT receptor counterpart, thereby reducing or altering signal transduction.
Increased Met activation via met and/or met+hgf/sf transfection into DA3 cells resulted in increased tumor and metastasis formation, as well as increased mortality rate of mice injected with these transfected cells, compared to mice injected with control cells. These observations are in concordance with previous work showing that cells co-expressing HGF/SF and Met display increased invasiveness in vitro (Jeers et al., 1996a) . Co-expression of Met and HGF/SF is abundant in invasive breast carcinoma as compared with benign breast tissue . Moreover, it was shown that Met is up-regulated in breast cancer biopsies and that Met as well as HGF/SF levels can serve as prognostic markers for breast cancer (Ghoussoub et al., 1998) .
DA3-DN cells display dramatically reduced HGF/ SF-dependent motility (scattering) and invasiveness in vitro as compared to the parental cells and met+hgf/sf transfected cells. Furthermore, in vivo we observed dramatic reduction in tumor and metastasis formation accompanied by improved survival in mice injected with DN-Met cells. DA3-DN cells proliferate slightly faster than parental DA3 or hgf-sf transfected cells. These results indicate that invasiveness, rather than proliferation rate, has greater signi®cance in determining the tumorigenic-metastatic potential of breast cancer cells. Our results, which demonstrate the signi®cance of Met in the invasive process, are corroborated by other publications showing that most lymph node metastases have higher Met expression than primary tumors (Beviglia et al., 1997) . In other cancers it was shown that distant metastases express high levels of Met compared to the primary tumor, suggesting that the presence of Met receptor may contribute to the acquisition of an invasive phenotype (Di Renzo et al., 1994 Renzo et al., , 1995 Natali et al., 1993) . Tumors resulting from the DA3-DN cells were highly dierentiated and contained glandular structures, while injection of DA3 with increased Met signaling resulted in undierentiated tumors with fewer and smaller glandular structures. These results imply that loss of tubule formation may be reversible via alteration of Met signal transduction.
Although we show down-regulation of Met phosphorylation by the DN-Met, the molecular mechanisms underlying the DN mediated biological eects are as yet unclear. These biological eects may be caused solely by the DN-induced reduction in Met phosphorylation; another possibility is that the DN form associated with the WT receptor activates alternate signal transduction pathways responsible for tubule formation. Possibly, the dierentiative signaling pathways induce the expression of dierent proteins, for example; cell ± cell and cell ± matrix proteins in DN ± Met cells, while met+hgf/sf-transfected cells express proteases. Recently it was shown that tubulogenesis is dependent on the STAT pathway: Met binds and phosphorylates STAT which subsequently translocates to the nucleus, binds to the speci®c promoter element SIE and modulates the expression of genes which lead to dierentiation, including c-fos and waf-1 (Boccaccio et al., 1998) . Thus, a possible explanation for our results could be that an up-regulation in Met signaling results in increased signaling in the Ras-Src pathway, while reduction in Met signaling via the DN receptor induces signaling through the STAT pathway.
We have recently shown that breast cancer patients with either up-regulation or down-regulation of Met expression in the tumor have poor prognosis. We hypothesize that while cells with high Met expression have a greater invasive and metastatic potential, Met can act adversely at low levels by not allowing cells to fully dierentiate into tubular structures (Tsarfaty et al., AQCH in press) . The model system presented in this paper indicates that Met activity can change the fate of the cells and explain the dual function of Met in breast cancer. This hypothesis is substantiated by recent work on branching in the Drosophila tracheal system. Regulation of branching in this system is achieved by modulation of signal transduction levels of the FGF-receptor homolog breathless (Btl), expressed on tracheal cells (Hacohen et al., 1998) .
In our system, up-regulated Met signaling leads to increased tumorigenesis/metastasis, while down-regulating the signal via the DN receptor results in increased tubulogenesis. Thus, alterations in Met signaling can shift the balance between dierentiation and invasiveness, changing the cells' fate from nondierentiated invasive cells to gland-forming cells. Using a therapeutic modality that induces cell dierentiation has been suggested for many malignancies. Down-regulating Met activity in patients with high Met activity can lead to reduced tumorigenicity ± metastasis and increased dierentiation, providing a basis for new therapeutic strategies. Such strategies may include gene therapy using a dominant negative form of the receptor as presented in this paper. However, a more pragmatic approach would be to ®nd substances, such as HGF/SF competitors or speci®c Met phosphorylation inhibitors, capable of impeding Met activity.
Materials and methods
Cell lines, animals, cDNA plasmids and antibodies D1-DMBA-3 is a cell line derived from a poorly dierentiated mammary adenocarcinoma induced in BALB/C mice by dimethylbenzanthracene. Limiting dilution cloning produced the cell line designated DA3 (Fu et al., 1990) . DA3 and transfectants were grown in DMEM (Gibco ± BRL Gaithersburg, MD, USA) supplemented with 10% heat-inactivated fetal calf serum (FCS) (Gibco ± BRL). MDCK epithelial cells (type 2) provided by Dr KE Mostov (University of California San Francisco, San Francisco, CA, USA) were grown in DMEM (Gibco ± BRL) supplemented with 5% heat-inactivated FCS (Gibco ± BRL). HMH cells ± NIH3T3 cells transfected with human met and human hgf/sf ± were maintained as described previously (Rong et al., 1992) . 293 and transfectants were grown in DMEM (Gibco ± BRL) supplemented with 10% heat-inactivated FCS (Gibco ± BRL). Human hgf/sf plasmid was constructed by inserting the 2.3 kb BamHI ± KpnI fragment of the human HGF/SF sequence (Nakamura et al., 1989) into the BamHI-KpnI site of pMEX (Rong et al., 1992) . The following antibodies were used: Rabbit polyclonal SP260 anti murine Met peptide antibody (Santa Cruz Biotechnology, Santa Cruz, CA, USA) (Gonzatti-Haces et al., 1988) , Rabbit polyclonal anti recombinant human HGF/SF antibody (Rong et al., 1993) , and anti-phosphotyrosine 4G10 mAb (UBI, NY, USA).
Construction of dominant negative met expression vectors
Mouse met cDNA was used to construct DN form of Met by deleting part of the met tyrosine kinase domain which spans between base pairs 3247 and 3984 or by point mutating of three tyrosines (Tyr) in the Met docking site. The pMB11 plasmid, containing the full-length mouse met cDNA (Rong et al., 1992) was partially cleaved by BglII restriction enzyme and self-ligated omitting base pairs 2880 ± 3531, thus removing a crucial part of the met tyrosine kinase domain (pMBTDN). The plasmid containing the full-length mouse met cDNA was point-mutated at three dierent positions (pMFDN) as previously described (Jeers et al., 1997) . In short, we mutated the Tyr in position 1347 to Phenylalanine (Phe) (TAC to TTC, nucleotide 4039 ± 4041 in mouse met sequence), Tyr in positions 1354 to Phe (TAT to TTT, nucleotide 4060 ± 4062 in mouse met sequence) and the Tyr in positions 1363 to Phe (TAT to TTT, nucleotide 4087 ± 4089 in mouse met sequence). Mutations were con®rmed by sequencing. pTDN-HA plasmid was constructed by partial restriction using BglII removing base pairs 2880 ± 3531 and ligation with an oligonucleotide pair (positive and negative strand) containing two copies of the in¯uenza hemagglutinin epitope.
DNA transfection
Stable transfection: The Lipofectin reagent kit (Gibco ± BRL) was used for DNA transfection. DA3 cells at 70% con¯uence were either co-transfected with 4 mg human hgf/sf (DA3H), pMB11 (DA3M), human hgf/sf and pMB11 (DA3MH), pMBTDN (TDN), pMBTDN-HA (PL-TDN-HA and TDN-HA clones) or pMFDN (PL-FDN) and F1DN) and pSTneo plasmids (1 : 1) or with pSTneo (DA3N) (Rong et al., 1992) . The plasmids were suspended in buer solutions and added to the DA3 cells as recommended by manufacturer. After 18 h of incubation at 378C, the transfection mixture was replaced with DMEM medium containing 10% FCS. After 72 h incubation at 378C, the transfected cells were divided 1 : 5, incubated in DMEM medium containing 10% FCS and 100 mg/ml of G418 (Gibco ± BRL) and resistant clones were isolated or pooled.
Transient transfection: 293 cells were transfected with pMB11 (293-Met), pMBTDN met (293-TDN) or pMFDN (293-FDN) using the calcium co-precipitation technique (Gorman et al., 1982) .
Immunofluorescence staining and confocal analysis
Eight well Lab-Tek chamber slides (Nunc, Denmark) were seeded with 10 4 cells per well in medium containing 10% FCS. Cells were ®xed in absolute methanol for 10 min and consequently permeabilized with cold acetone for 10 min. Following blocking (1% BSA, 10% normal donkey serum in phosphate buered saline ± PBS) for 10 min at room temperature, cells were incubated with primary antibody diluted 1 : 50 for 1 h at room temperature. Following three washes in PBS, cells were incubated with donkey anti rabbit or anti mouse antibody conjugated either to¯uorescein isothiocyanate (FITC) or Texas Red (Jackson Immuno Research Laboratories, INC West Grove, PA, USA) diluted 1 : 50 for 1 h at room temperature. Cells were washed three times in PBS and coverslipped with gel mount (Biomeda, Foster City, CA, USA).
Fluorochrome-labeled cells were analysed using a 410 Zeiss (Oberkochen, Germany) confocal laser scanning microscope (CLSM) with the following con®guration: 25 mW HeNe lasers (633 nm) and Krypton Argon (488, 568 and 647 nm) laser lines. When comparing¯uorescence intensity, identical parameters were used for each image (e.g., scanning line, laser light, contrast brightness). Images were printed using Codonics dye sublimation color printer.
Mitogenic assay
Cells (2500/well) were seeded into 96-well microtiter plates with or without HGF/SF (80 u/ml) and incubated for 24 ± 96 h. Following incubations, 25 ml of MTT (3-(4,5-dimethylthiazol-2-yl)-2,5 diphenyl-tetrazolium bromide, Sigma) were added to 100 ml of medium in each well and plates were incubated for 2 h. Subsequently, 100 ml of isopropanol+0.13% HCl were added to each well and mixed vigorously. The product of the reaction was determined by using an ELISA reader (Bio-tek instruments, Winooski, VT, USA) at wavelengths of 570/630 nm.
Scatter assay
Scatter assay was carried out as previously described (Rosen et al., 1989; Stoker et al., 1987) . Assay medium (DMEM with 5% calf serum, GIBCO) with or without HGF/SF (80 u/ml) was added in 150 ml to 96 well plates (Costar). Cells (5000 cells/well) were added in 150 ml assay medium and incubated overnight. Cells were ®xed, air dried, stained with Giemsa and examined for scattering (spreading and dispersion of epithelial colonies). The highest dilution at which scatter eect was observed was de®ned as 0.5 HGF/SF scatter unit (u) per ml.
In vitro invasion assay
Invasion assays were performed as previously described by Albini et al. (1987) in 96-well chemotaxis chambers (NeuroProbe, MD, USA). Lower and upper wells were separated by Nucleopore ®lters (8 mm pore size) coated with Matrigel (1 mg/mm 2 , Collaborative Research). Eighty u/ml of HGF/SF diluted in 30 ml DMEM containing 1 mg/ml BSA was placed in lower wells. Cells (3.6610 4 ) in DMEM-BSA were placed in upper wells and chambers were incubated overnight. Noninvading cells remaining on the upper surface were removed with a cotton swab and invading cells that migrated to the lower surface of ®lter were ®xed with cold methanol and stained with Giemsa (Sigma). The stained ®lter was scanned and the area occupied by stained cells (upper threshold 214; lower threshold 1) was analysed using Optimas image analysis software (Seattle, WA, USA). The average and standard deviation was calculated for each transfectant and the statistical dierence was calculated using Anova.
Tubule formation in collagen
2610
5 DA3N, TDN and F1DN cells were seeded in 24-well plates in 0.5 ml of 0.6 mg/ml collagen. HGF/SF (80 u/ml) was added (+) or not added (7) to appropriate wells. Following 5-day incubation, collagen gels were ®xed using 4% paraformaldehyde+0.1% triton and imaged by Nomarski, dierential interference contrast microscopy (N/DIC).
Western blot analysis of HGF/SF
Supernatants (8 ml) were collected from con¯uent cells, ®ltered and incubated with 0.2 mg/ml heparin sepharose (HS) (Pharmacia-Bio-tec, Uppsala, Sweden) for 2 h at room temperature. Following incubation the HS was washed63 with PBS. Pellets were suspended in sample buer, resolved in 12% SDS ± PAGE and analysed by Western blot analysis using rabbit anti HGF/SF antibody diluted 1 : 350. Visualization was achieved using HRP-conjugated anti-mouse IgG antibody (1 : 5000) (Amersham, Arlington Heights, IL, USA), ECL reaction and exposure to X-ray ®lm (Fuji, Japan).
Immunoprecipitation and Western blot analysis of Met and Met tyrosine phosphorylation
Near-con¯uent cells were treated with HGF/SF (80 u/ml) for 0, 5, 10, 20, 30 and 60 min at room temperature. Cells were washed twice with cold PBS and lysed in 1 ml lysis buer (20 mM Tris-HCl, pH 7.8, 100 mM NaCl, 50 mM NaF, 1% NP40, 0.1% SDS, 2 mM EDTA, 10% glycerol) with protease inhibitor cocktail (Boehringer Mannheim, Germany) and 1 mM sodium orthovanadate. Cell lysates were clari®ed by centrifugation and 1 mg cell lysate protein was IP with SP260 anti Met Ab. The immunoprecipitates were subjected to WB analysis using either SP260 antibody (1 : 500) or 4G10 anti-pTyr antibody (1 : 1500). Visualization was achieved using HRP-conjugated anti-mouse IgG antibody or HRP-conjugated protein A (1 : 5000) (Amersham, Arlington Heights, IL, USA), ECL reaction and exposure to X-ray ®lm (Fuji, Japan).
In vivo tumor formation and survival analysis Cells were trypsinized, washed twice and resuspended in PBS. 5610 4 cells in 0.2 ml PBS were injected intra-muscularly into the leg of BALB/C mice. Tumor formation was monitored twice weekly. After 56 days, mice were sacri®ced and tumor and lung were collected and ®xed in formalin, embedded in paran, sectioned, stained with hematoxylin and eosin (H&E) and analysed by light microscopy using histopathological morphological criteria.
Statistical analysis
Analyses of tumor-free and overall survival were performed with Kaplan ± Meier (Kaplan and Meier, 1958) and tests for dierences between survival curves were made with the logrank statistic using SAS (SAS Institute Inc., SAS/STAT Software: Changes and Enhancements through Release 6.11, Cary, NC, 1996) .
Tests for statistical dierences between groups were performed using Student's t-test and Anova (Microsoft Excel).
